NeuroTimone Facility (PFNT)

The PFNT Facility is a coherent set of exploration tools in neurobiology allowing research at the molecular, cellular and integrated levels.


  1. INP day

    On 28/09/2023, the whole laboratory took part in the Institute's annual day.

    It was an excellent day, with a scientific morning devoted to discovering the research topics of all the teams and Vect'horus, followed by a fun afternoon of intellectual and sporting competitions to win a treasure.

    Once again, the GlioME team was delighted to take part in this fun-filled day.

  2. Paper out! New publication from the SynapTau Team (Team 2')

    The SynapTau team is thrilled to announce the publication of our collaborative work. This has been an incredible partnership, and we are delighted to share our findings in the journal Life Science Alliance! In this paper, we demonstrated that parenchymal border macrophages (PBMs) function impedes tau pathology and tau-mediated neurodegeneration, while tau pathology promotes PBM dysfunction associated with impaired CSF flow. Our results identify PBMs as novel cellular regulators of tau pathology and tau-mediated neurodegeneration.

  3. Just out! New publication from the GlioME Team (Team 8)

    The GlioME Team has new publication out in International Journal of Molecular Sciences as part of the Special Issue « Emerging Therapies for Glioblastoma ». This article deals with one of the team’s key issues, the gangliosides recognized by the A2B5 antibody and used as biomarker of cancer stem cells (CSC) in glioblastoma human brain tumours. To tackle these CSC known to be resistant to conventional treatment, the GlioME team aimed to better understand the effect of neuraminidase administration that removes A2B5, on an organotypic three-dimensional glioblastoma model.

  4. First Ma Terre en 180' workshop at the INP !

    On July 6, 5 INP members took part in the first Ma Terre en 180' workshop organized by Louise Greetham (Team 6/SCENT) and Santiago Rivera (Team 1). MT 180' is the 1st collaborative workshop from the academic world to build scenarios for reducing carbon footprint within a research laboratory. Congratulations to Fanny (aka Maggie), Laure (aka Zara), Theresa (aka Claire), Géraldine (aka David) and Ivan (aka Benjamin) for their participation and commitment. They succeeded in reducing the carbon footprint of their virtual Geophysics laboratory by over 50%. 

  5. 5th French Microtubule Network days

    Since the first event in Marseille in 2013, initiated by François Devred and Stéphane Honoré, the French microtubule network has been organizing colloquia bringing together researchers, post-docs and students from more than 34 laboratories, every 2 years in a different city. After Grenoble (2015), Versailles (2017), and Rennes (2019), the fifth edition of the congress of french scientists working on microtubules took place on June 29 and 30, 2023 in Montpellier. 

    The occasion for José Luis to present the team's work on Snake venom myotoxins as microtubule-targeting peptides

  6. ICI summerschool: Workshop on tumoroids

    The GlioME team was delighted to take part in the tumoroids workshop at the summerschool organized by the Institute of Cancer and Immunology. For one day, the team welcomed 8 international students to introduce them to the preparation of human glioblastoma tumoroids. A day rich in scientific and human exchanges.


  7. 2023 Cancéropôle PACA Annual Seminar

    Teams 8 and 9, along with the PINT and PETRA Network platforms, represented the lab at the Canceropôle Provence-Alpes-Côte d'Azur annual seminar. Another opportunity to highlight the work of our PhDstudents and researchers.

    Rayane Hedna,  Victoria Hein and Emmanuel Snacel-Fazy took up the challenge of the "teasing poster" session.

  8. Posters presented by two BUT students

    The GlioME team and the PETRA platform welcomed two BUT students, Ludivine Rouillon and Emilie Louat, for their end-of-year internship.

    Their internship ended with a presentation of their work as posters entitled: "Développement d'un modèle pré-clinique 3D de tumoroïdes dérivé de tumeurs du SNC pour l'étude de molécules thérapeutiques" and "Analyse de l'expression de la protéine AP après traitement au témozolomide ou radiothérapie dans le glioblastome". 


INP in numbers

  • 126 members
  • 44 researchers
  • 48 research assistants
  • 12 post-docs
  • 11 PhD